LC
PEARW

Littlejohn & Co’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Littlejohn & Co’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,332
Closed -$158 – 64
2023
Q1 		$158 Buy
+8,332
New +$802 ﹤0.01% 61

Other funds holding PEARW

AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Littlejohn & Co's PEARW Position: Q2 2023 in Review

Littlejohn & Co sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 8,332 shares — an estimated $158 sold.

Littlejohn & Co first reported a position in PEARW in Q1 2023 and held it in 1 quarter. The position peaked at $158 in Q1 2023. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

  • Littlejohn & Co reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
  • Littlejohn & Co sold 8,332 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $158.
  • Littlejohn & Co first reported a position in Pear Therapeutics, Inc. Warrant in Q1 2023 and held it in 1 quarter.
  • Littlejohn & Co's Pear Therapeutics, Inc. Warrant position peaked at $158 in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Littlejohn & Co's 13F filing for Q2 2023, filed 9 Aug 2023.